Search

everythinglearnresearchcommunity

for

Search:↓

Both HLA-B and MICA are independently linked to alopecia areata.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Certain genes are linked to the risk of developing Alopecia Areata.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Corneodesmosin is essential for skin and hair health, and its dysfunction can lead to skin and hair disorders.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.